SLC19A2
Basic information
Region (hg38): 1:169463909-169485944
Previous symbols: [ "TRMA" ]
Links
Phenotypes
GenCC
Source:
- thiamine-responsive megaloblastic anemia syndrome (Strong), mode of inheritance: AR
- thiamine-responsive megaloblastic anemia syndrome (Strong), mode of inheritance: AR
- thiamine-responsive megaloblastic anemia syndrome (Definitive), mode of inheritance: AR
- thiamine-responsive megaloblastic anemia syndrome (Supportive), mode of inheritance: AR
- thiamine-responsive megaloblastic anemia syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thiamine-responsive megaloblastic anemia syndrome | AR | Endocrine; Hematologic | High-dose thiamine can improve anemia and may ameliorate diabetes; Individuals may also have sensorineural hearing loss, but prelingual onset appears to have not been reported | Audiologic/Otolaryngologic; Endocrine; Hematologic | 5767338; 671156; 6175336; 2540004; 1326679; 7707690; 10391221; 10391223; 10074490; 10978358; 19643445; 20301459; 22369132; 22576805; 22876572 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (27 variants)
- Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness (10 variants)
- Ear malformation (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC19A2 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 128 | 131 | ||||
missense | 130 | 142 | ||||
nonsense | 15 | 17 | ||||
start loss | 0 | |||||
frameshift | 12 | 16 | ||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 29 | 14 | 137 | 131 | 0 |
Highest pathogenic variant AF is 0.000013142
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC19A2 | protein_coding | protein_coding | ENST00000236137 | 6 | 22095 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000434 | 0.992 | 125710 | 0 | 38 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.192 | 263 | 272 | 0.967 | 0.0000136 | 3165 |
Missense in Polyphen | 123 | 117.07 | 1.0507 | 1440 | ||
Synonymous | 0.302 | 104 | 108 | 0.963 | 0.00000539 | 1061 |
Loss of Function | 2.36 | 9 | 20.6 | 0.438 | 0.00000105 | 221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: High-affinity transporter for the intake of thiamine. {ECO:0000269|PubMed:10391222, ECO:0000269|PubMed:10542220}.;
- Pathway
- Vitamin digestion and absorption - Homo sapiens (human);Thiamine Metabolism;Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;Vitamin B1 (thiamin) metabolism;Vitamin B1 (thiamin) metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.258
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.282
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.323
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc19a2
- Phenotype
- immune system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- folic acid transport;thiamine transport;thiamine-containing compound metabolic process;transmembrane transport;thiamine transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- protein binding;folic acid transmembrane transporter activity;thiamine transmembrane transporter activity